Skip to main content

Detection of Loss of Heterozygosity in Tk-Deficient Mutants from L5178Y Tk+/−-3.7.2C Mouse Lymphoma Cells

  • Protocol
  • First Online:
Molecular Toxicology Protocols

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2102))

Abstract

The mouse lymphoma assay (MLA), a forward mutation assay using the Tk+/−-3.7.2C clone of the L5178Y mouse lymphoma cell line and the Thymidine kinase (Tk) gene, has been widely used as an in vitro genetic toxicity assay for more than four decades. The MLA can evaluate the ability of mutagens to induce a wide range of genetic events including both gene mutations and chromosomal mutations and has been recommended as one component of several genotoxicity test batteries. Tk-deficient mutants often exhibit chromosomal abnormalities involving the distal end of chromosome 11 where the Tk gene is located, in mice, and the type of chromosome alteration can be analyzed using a loss of heterozygosity (LOH) approach. LOH has been considered an important event in human tumorigenesis and can result from any of the following several mechanisms: large deletions, mitotic recombination, and chromosome loss. In this chapter, the authors describe the procedures for the detection of LOH in the Tk mutants from the MLA, and apply LOH analysis for understanding the types of genetic damage that is induced by individual chemicals.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Clive D, Flamm WG, Machesko MR, Bernheim NJ (1972) A mutational assay system using the thymidine kinase locus in mouse lymphoma cells. Mutat Res 16(7):77–87

    CAS  Google Scholar 

  2. OECD (1997) In vitro mammalian cell gene mutation test, OECD Guideline for Testing of Chemicals, No. 476. http://www.oecd.org/chemicalsafety/assessmentofchemicals/1948426.pdf Accessed 20 Dec 2018

  3. FDA (2000) Redbook 2000: IV.C.1.c Mouse lymphoma thymidine kinase gene mutation assay. https://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/IngredientsAdditivesGRASPackaging/ucm078336.htm. Accessed 28 Nov 2018

  4. Dearfield KL, Auletta AE, Cimino MC, Moore MM (1991) Considerations in the U.S. Environmental Protection Agency’s testing approach for mutagenicity. Mutat Res 258(3):259–283

    CAS  PubMed  Google Scholar 

  5. ICH (2011) Guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use S2(R1). http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S2_R1/Step4/S2R1_Step4.pdf. Accessed 28 Nov 2018

  6. Clive D, Johnson KO, Spector JF, Batson AG, Brown MM (1979) Validation and characterization of the L5178Y/TK+/− mouse lymphoma mutagen assay system. Mutat Res 59(1):61–108

    CAS  PubMed  Google Scholar 

  7. Cole J, Arlett CF, Green MH, Lowe J, Muriel W (1983) A comparison of the agar cloning and microtitration techniques for assaying cell survival and mutation frequency in L5178Y mouse lymphoma cells. Mutat Res 111(3):371–386

    CAS  PubMed  Google Scholar 

  8. Oberly TJ, Yount DL, Garriott ML (1997) A comparison of the soft agar and microtitre methodologies for the L5178Y Tk+/− mouse lymphoma assay. Mutat Res 388(1):59–66

    CAS  PubMed  Google Scholar 

  9. Chen T, Moore MM (2004) Screening for chemical mutagens using the mouse lymphoma assay. In: Yan Z, Caldwell GW (eds) Optimization in drug discovery: in-vitro methods. Humana Press, Totowa, NJ, pp 337–352

    Google Scholar 

  10. Mei N, Guo X, Moore MM (2014) Methods for using the mouse lymphoma assay to screen for chemical mutagenicity and photo-mutagenicity. In: Caldwell GW, Yan Z (eds) Optimization in drug discovery: in vitro methods. Methods in pharmacology and toxicology. Humana Press, New York, pp 561–592

    Google Scholar 

  11. Chen T, Guo X, Moore MM (2014) The mouse lymphoma assay. In: Sierra L, Gaivão I (eds) Methods in pharmacology and toxicology: genotoxicity and DNA repair. Humana Press, New York, NY, pp 323–342

    Google Scholar 

  12. Clements J (2000) The mouse lymphoma assay. Mutat Res 455(1-2):97–110

    CAS  PubMed  Google Scholar 

  13. Schisler MR, Moore MM, Gollapudi BB (2013) In vitro mouse lymphoma (L5178Y Tk+/−-3.7.2C) forward mutation assay. In: Dhawan A, Bajpayee M (eds) Methods in molecular biology: genotoxicity assessment, vol 1044. Humana Press, Totowa, NJ, pp 27–50

    Google Scholar 

  14. Moore MM, Honma M, Clements J, Awogi T, Bolcsfoldi G, Cole J, Gollapudi B, Harrington-Brock K, Mitchell A, Muster W, Myhr B, O'Donovan M, Ouldelhkim MC, San R, Shimada H, Stankowski LF Jr (2000) Mouse lymphoma thymidine kinase locus gene mutation assay: International Workshop on Genotoxicity Test Procedures Workgroup Report. Environ Mol Mutagen 35(3):185–190

    CAS  PubMed  Google Scholar 

  15. Moore MM, Honma M, Clements J, Harrington-Brock K, Awogi T, Bolcsfoldi G, Cifone M, Collard D, Fellows M, Flanders K, Gollapudi B, Jenkinson P, Kirby P, Kirchner S, Kraycer J, McEnaney S, Muster W, Myhr B, O’Donovan M, Oliver J, Ouldelhkim MC, Pant K, Preston R, Riach C, San R, Shimada H, Stankowski LF Jr (2002) Mouse lymphoma thymidine kinase gene mutation assay: follow-up International Workshop on Genotoxicity Test Procedures, New Orleans, Louisiana, April 2000. Environ Mol Mutagen 40(4):292–299

    CAS  PubMed  Google Scholar 

  16. Moore MM, Honma M, Clements J, Bolcsfoldi G, Cifone M, Delongchamp R, Fellows M, Gollapudi B, Jenkinson P, Kirby P, Kirchner S, Muster W, Myhr B, O’Donovan M, Oliver J, Omori T, Ouldelhkim MC, Pant K, Preston R, Riach C, San R, Stankowski LF Jr, Thakur A, Wakuri S, Yoshimura I (2003) Mouse lymphoma thymidine kinase gene mutation assay: International Workshop on Genotoxicity Tests Workgroup report—Plymouth, UK 2002. Mutat Res 540(2):127–140

    CAS  PubMed  Google Scholar 

  17. Moore MM, Honma M, Clements J, Bolcsfoldi G, Burlinson B, Cifone M, Clarke J, Delongchamp R, Durward R, Fellows M, Gollapudi B, Hou S, Jenkinson P, Lloyd M, Majeska J, Myhr B, O’Donovan M, Omori T, Riach C, San R, Stankowski LF Jr, Thakur AK, Van Goethem F, Wakuri S, Yoshimura I (2006) Mouse lymphoma thymidine kinase gene mutation assay: follow-up meeting of the International Workshop on Genotoxicity Testing—Aberdeen, Scotland, 2003—Assay acceptance criteria, positive controls, and data evaluation. Environ Mol Mutagen 47(1):1–5

    CAS  PubMed  Google Scholar 

  18. Moore MM, Honma M, Clements J, Bolcsfoldi G, Burlinson B, Cifone M, Clarke J, Clay P, Doppalapudi R, Fellows M, Gollapudi B, Hou S, Jenkinson P, Muster W, Pant K, Kidd DA, Lorge E, Lloyd M, Myhr B, O’Donovan M, Riach C, Stankowski LF Jr, Thakur AK, Van Goethem F (2007) Mouse lymphoma thymidine kinase gene mutation assay: meeting of the International Workshop on Genotoxicity Testing, San Francisco, 2005, recommendations for 24-h treatment. Mutat Res 627(1):36–40

    CAS  PubMed  Google Scholar 

  19. Moore MM, Honma M, Clements J, Awogi T, Douglas GR, van Goethem F, Gollapudi B, Kimura A, Muster W, O'Donovan M, Schoeny R, Wakuri S (2011) Suitable top concentration for tests with mammalian cells: mouse lymphoma assay workgroup. Mutat Res 723(2):84–86

    CAS  PubMed  Google Scholar 

  20. OECD (2015) In vitro mammalian cell gene mutation tests using the thymidine kinase gene, OECD Guideline for Testing of Chemicals, No. 490. http://www.oecd-ilibrary.org/environment/test-no-490-in-vitro-mammalian-cell-gene-mutation-tests-using-the-thymidine-kinase-gene_9789264242241-en. Accessed 28 Nov 2018

  21. Moore MM, Clive D, Hozier JC, Howard BE, Batson AG, Turner NT, Sawyer J (1985) Analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/− mouse lymphoma cells. Mutat Res 151(1):161–174

    CAS  PubMed  Google Scholar 

  22. Moore MM, Clive D, Howard BE, Batson AG, Turner NT (1985) In situ analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/− mouse lymphoma cells. Mutat Res 151(1):147–159

    CAS  PubMed  Google Scholar 

  23. Applegate ML, Moore MM, Broder CB, Burrell A, Juhn G, Kasweck KL, Lin PF, Wadhams A, Hozier JC (1990) Molecular dissection of mutations at the heterozygous thymidine kinase locus in mouse lymphoma cells. Proc Natl Acad Sci U S A 87(1):51–55

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Wang J, Sawyer JR, Chen L, Chen T, Honma M, Mei N, Moore MM (2009) The mouse lymphoma assay detects recombination, deletion, and aneuploidy. Toxicol Sci 109(1):96–105

    CAS  PubMed  Google Scholar 

  25. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL (1983) Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305(5937):779–784

    CAS  PubMed  Google Scholar 

  26. Honma M (2005) Generation of loss of heterozygosity and its dependency on p53 status in human lymphoblastoid cells. Environ Mol Mutagen 45(2-3):162–176

    CAS  PubMed  Google Scholar 

  27. Honma M, Momose M, Sakamoto H, Sofuni T, Hayashi M (2001) Spindle poisons induce allelic loss in mouse lymphoma cells through mitotic non-disjunction. Mutat Res 493(1-2):101–114

    CAS  PubMed  Google Scholar 

  28. Liechty MC, Scalzi JM, Sims KR, Crosby H Jr, Spencer DL, Davis LM, Caspary WJ, Hozier JC (1998) Analysis of large and small colony L5178Y tk−/− mouse lymphoma mutants by loss of heterozygosity (LOH) and by whole chromosome 11 painting: detection of recombination. Mutagenesis 13(5):461–474

    CAS  PubMed  Google Scholar 

  29. Liechty MC, Hassanpour Z, Hozier JC, Clive D (1994) Use of microsatellite DNA polymorphisms on mouse chromosome 11 for in vitro analysis of thymidine kinase gene mutations. Mutagenesis 9(5):423–427

    CAS  PubMed  Google Scholar 

  30. Chen T, Harrington-Brock K, Moore MM (2002) Mutant frequency and mutational spectra in the Tk and Hprt genes of N-ethyl-N-nitrosourea-treated mouse lymphoma cellsdagger. Environ Mol Mutagen 39(4):296–305

    CAS  PubMed  Google Scholar 

  31. Guo X, Pan B, Seo JE, Chen Y, Yan J, Mei N, Chen T (2018) Whole genome sequencing analysis of small and large colony mutants from the mouse lymphoma assay. Arch Toxicol 92(12):3585–3595

    CAS  PubMed  Google Scholar 

  32. Mei N, Hu J, Churchwell MI, Guo L, Moore MM, Doerge DR, Chen T (2008) Genotoxic effects of acrylamide and glycidamide in mouse lymphoma cells. Food Chem Toxicol 46(2):628–636

    CAS  PubMed  Google Scholar 

  33. Chen T, Harrington-Brock K, Moore MM (2002) Mutant frequencies and loss of heterozygosity induced by N-ethyl-N-nitrosourea in the thymidine kinase gene of L5178Y/TK(+/−)-3.7.2C mouse lymphoma cells. Mutagenesis 17(2):105–109

    CAS  PubMed  Google Scholar 

  34. Mei N, Zhang Y, Chen Y, Guo X, Ding W, Ali SF, Biris AS, Rice P, Moore MM, Chen T (2012) Silver nanoparticle-induced mutations and oxidative stress in mouse lymphoma cells. Environ Mol Mutagen 53(6):409–419

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Guo X, Verkler TL, Chen Y, Richter PA, Polzin GM, Moore MM, Mei N (2011) Mutagenicity of 11 cigarette smoke condensates in two versions of the mouse lymphoma assay. Mutagenesis 26(2):273–281

    CAS  PubMed  Google Scholar 

  36. Lin H, Guo X, Zhang S, Dial SL, Guo L, Manjanatha MG, Moore MM, Mei N (2014) Mechanistic evaluation of Ginkgo biloba leaf extract-induced genotoxicity in L5178Y cells. Toxicol Sci 139(2):338–349

    CAS  PubMed  Google Scholar 

  37. Guo X, Zhang S, Dial SL, Boudreau MD, Xia Q, Fu PP, Levy DD, Moore MM, Mei N (2014) In vitro investigation of the mutagenic potential of aloe vera extracts. Toxicol Res 3:487–496

    CAS  Google Scholar 

  38. Singh SP, Chen T, Chen L, Mei N, McLain E, Samokyszyn V, Thaden JJ, Moore MM, Zimniak P (2005) Mutagenic effects of 4-hydroxynonenal triacetate, a chemically protected form of the lipid peroxidation product 4-hydroxynonenal, as assayed in L5178Y/Tk+/− mouse lymphoma cells. J Pharmacol Exp Ther 313(2):855–861

    CAS  PubMed  Google Scholar 

  39. Guo X, Mittelstaedt RA, Guo L, Shaddock JG, Heflich RH, Bigger AH, Moore MM, Mei N (2013) Nitroxide TEMPO: a genotoxic and oxidative stress inducer in cultured cells. Toxicol In Vitro 27(5):1496–1502

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Guo X, Seo JE, Bryce SM, Tan JA, Wu Q, Dial SL, Moore MM, Mei N (2018) Comparative genotoxicity of TEMPO and 3 of its derivatives in mouse lymphoma cells. Toxicol Sci 163(1):214–225

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Mei N, Xia Q, Chen L, Moore MM, Chen T, Fu PP (2006) Photomutagenicity of anhydroretinol and 5,6-epoxyretinyl palmitate in mouse lymphoma cells. Chem Res Toxicol 19(11):1435–1440

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Mei N, Xia Q, Chen L, Moore MM, Fu PP, Chen T (2005) Photomutagenicity of retinyl palmitate by ultraviolet a irradiation in mouse lymphoma cells. Toxicol Sci 88(1):142–149

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Mei N, Hu J, Xia Q, Fu PP, Moore MM, Chen T (2010) Cytotoxicity and mutagenicity of retinol with ultraviolet A irradiation in mouse lymphoma cells. Toxicol In Vitro 24(2):439–444

    CAS  PubMed  Google Scholar 

  44. Liechty MC, Crosby H Jr, Murthy A, Davis LM, Caspary WJ, Hozier JC (1996) Identification of a heteromorphic microsatellite within the thymidine kinase gene in L5178Y mouse lymphoma cells. Mutat Res 371(3-4):265–271

    CAS  PubMed  Google Scholar 

  45. Claudio JO, Malo D, Rouleau GA (1994) The mouse neurofibromatosis type 2 gene maps to chromosome 11. Genomics 21(2):437–439

    CAS  PubMed  Google Scholar 

  46. Wang J, Chen T, Honma M, Chen L, Moore MM (2007) 3′-azido-3′-deoxythymidine induces deletions in L5178Y mouse lymphoma cells. Environ Mol Mutagen 48(3–4):248–257

    CAS  PubMed  Google Scholar 

  47. Cariello NF (1994) Software for the analysis of mutations at the human hprt gene. Mutat Res 312(2):173–185

    CAS  PubMed  Google Scholar 

  48. Adams WT, Skopek TR (1987) Statistical test for the comparison of samples from mutational spectra. J Mol Biol 194(3):391–396

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Drs. Tao Chen and Kelly Harris for their critical review of this manuscript. The information in this article is not a formal dissemination of information by the U.S. Food and Drug Administration (FDA) and does not represent Agency position or policy.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nan Mei .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Guo, X., Chen, Y., Moore, M.M., Mei, N. (2020). Detection of Loss of Heterozygosity in Tk-Deficient Mutants from L5178Y Tk+/−-3.7.2C Mouse Lymphoma Cells. In: Keohavong, P., Singh, K., Gao, W. (eds) Molecular Toxicology Protocols. Methods in Molecular Biology, vol 2102. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0223-2_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-0223-2_14

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-0222-5

  • Online ISBN: 978-1-0716-0223-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics